The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data


ÇETİNKAYA TEZER D. , YENİ S. N.

TURKISH JOURNAL OF NEUROLOGY, cilt.26, ss.10-13, 2020 (ESCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 26 Konu: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/tnd.galenos.2019.22755
  • Dergi Adı: TURKISH JOURNAL OF NEUROLOGY
  • Sayfa Sayıları: ss.10-13

Özet

Objective: Patients with drug-resistant focal or generalized epilepsy are important in terms of treatment and polytherapy necessity, adverse effect profiles of drugs, and seizure control difficulties. Clobazam (CLB), which has a lesser sedative effect than other benzodiazepines, is frequently used in different countries. In this study, we aimed to present the results related to the demographic characteristics, adverse effects, and treatment efficacy of patients under CLB treatment.